EUVIMED · CrossrefZeitschrift
Blood Reviews
ISSN 0268-960X · Elsevier BV
Neueste Artikel
Environmental risk factors for acute myeloid leukemia in adults, a systematic review
The blind spots of post-transplant AML relapse: from clinical signal to mechanism-matched therapy
Immune landscape and immunotherapeutic strategies for the treatment of TP53-mutated acute myeloid leukemia
Immunity and inflammation in classic Hodgkin lymphoma: Bridging diagnosis, prognosis and precision medicine
Targeting tomorrow: Evaluation of novel agents for infants with KMT2A-rearranged acute lymphoblastic leukaemia
The humoral pathophysiology of immune thrombocytopenia: How close are we to patient-specific disease treatment?
How artificial intelligence may solve diagnostic and prognostic challenges in classic Hodgkin lymphoma
Dysbiosis and immunothrombosis – How platelets and the gut microbiome interact
Platelet biology and etiopathogenesis of congenital platelet disorders
Underreported and underreviewed: Addressing the gaps in TKI tolerability literature for chronic myeloid leukemia
Autoimmune hemolytic anemia: New frontiers in diagnosis and therapy
Towards achieving immune reset in autoimmune cytopenias: Insights from clinical experiences with B cell depleting therapies
The critical role of platelets in venous thromboembolism: Pathogenesis, clinical status, and emerging therapeutic strategies
Tackling myeloma bone disease: From pathophysiology to cutting-edge therapies
Advances in the critical care management for patients with hematological malignancies
Exploring the depths of hypogammaglobulinemia in lymphoid malignancies: Pathophysiology, clinical implications, management options, and future directions
Targeting the neonatal Fc receptor (FcRn) in hematologic conditions with a focus on warm autoimmune hemolytic anemia
Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibody
The new era of primary immune thrombocytopenia management in adults: A narrative review of current and emerging treatments
Practical guidance on the prevention and management of infection in multiple myeloma patients: A case-based approach
BTK inhibitors resistance in B cell malignancies: Mechanisms and potential therapeutic strategies
Bridging the evidence-to-practice gap: Advancing neonatal blood transfusion. A narrative review of recent guidelines
Bispecific antibodies for the treatment of hematologic malignancies: The magic is T-cell redirection
The intestinal flora: The key to unraveling heterogeneity in immune thrombocytopenia?
Impact of transcranial Doppler screening on stroke prevention in children and adolescents with sickle cell disease: A systematic review and meta-analysis
Neuro-toxicities of chemo- and immune-therapies in haematologic malignancies: from mechanism to management
Longitudinal clinical manifestations of Fanconi anemia: A systematized review
Autologous stem cell transplantation in AL amyloidosis: Muddy waters
From MGUS to multiple myeloma: Unraveling the unknown of precursor states
Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment
Jahrgänge
2026 · 592025 · 602024 · 662023 · 842022 · 602021 · 902020 · 522019 · 572018 · 502017 · 482016 · 482015 · 482014 · 302013 · 332012 · 412011 · 332010 · 352009 · 392008 · 362007 · 2942006 · 302005 · 312004 · 272003 · 372002 · 432001 · 222000 · 181999 · 211998 · 311997 · 261996 · 341995 · 311994 · 321993 · 331992 · 291991 · 361990 · 401989 · 381988 · 351987 · 39
EUVIMED